enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
Holders of 5% or more of ENGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of enGene Therapeutics Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 13G/A | 9.99%6.90M shares | 0.00 ppfrom 9.99% | Nov 18, 20252 filings | Aug 14, 2026 | SEC |
| BML Investment Partners, L.P. | 13G/A | 9.95%6.67M shares | +2.15 ppfrom 7.80% | May 13, 20262 filings | May 14, 2026 | SEC |
| Invus Global Management, LLC | 13G/A | 9.30%6.26M shares | +1.50 ppfrom 7.80% | May 5, 20262 filings | Aug 13, 2026 | SEC |
| Invus Global Management, LLC | 13G | 6.30%4.24M shares | New | Jan 27, 20261 filing | Jan 27, 2026 | SEC |
| Acorn Bioventures, L.P. | 13G | 5.00%3.36M shares | New | Jul 22, 20261 filing | Jul 22, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
44 Schedule 13D and 13G filings on enGene Therapeutics Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20265:19 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 9.99%6.90M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| Aug 14, 20264:49 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 0.00%0 shares | −7.10 ppfrom 7.10%Below 5% | Jun 30, 2026 | SEC |
| Aug 14, 20268:25 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 0.00%0 shares | −6.69 ppfrom 6.69%Below 5% | Jun 30, 2026 | SEC |
| Aug 13, 202611:40 AM ET | Invus Global Management, LLCand 7 others | 13G/A | 9.30%6.26M shares | +1.50 ppfrom 7.80% | Jun 30, 2026 | SEC |
| Aug 12, 20264:31 PM ET | Blue Owl Capital Holdings LP | 13G/A | 0.76%511.2K shares | –Below 5% | Jun 30, 2026 | SEC |
| Jul 22, 20269:14 AM ET | Acorn Bioventures, L.P.and 4 others | 13G | 5.00%3.36M shares | New | Jul 20, 2026 | SEC |
| May 15, 20261:12 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 0.00%0 shares | −5.97 ppfrom 5.97%Below 5% | Mar 31, 2026 | SEC |
| May 14, 202610:30 AM ET | BML Investment Partners, L.P. | 13G/A | 9.95%6.67M shares | +2.15 ppfrom 7.80% | May 12, 2026 | SEC |
| May 13, 20269:23 PM ET | BML Investment Partners, L.P. | 13G | 7.80%5.22M shares | New | May 8, 2026 | SEC |
| May 5, 202610:59 AM ET | Invus Global Management, LLCand 7 others | 13G/A | 7.80%5.25M shares | – | Mar 31, 2026 | SEC |
| Feb 17, 20266:09 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 7.10%4.77M shares | −2.80 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 17, 20263:00 PM ET | Cormorant Asset Management, LPand 1 other | 13G | 5.97%4.00M shares | New | Dec 31, 2025 | SEC |
| Feb 17, 202612:46 PM ET | Kynam Capital Management, LPand 2 others | 13G/A | 2.23%1.49M shares | −7.57 ppfrom 9.80%Below 5% | Dec 31, 2025 | SEC |
| Jan 27, 20262:18 PM ET | Invus Global Management, LLCand 7 others | 13G | 6.30%4.24M shares | New | Jan 21, 2026 | SEC |
| Nov 18, 20254:01 PM ET | Deep Track Capital, LPand 2 others | 13G | 6.69%4.32M shares | +2.32 ppfrom 4.37% | Nov 11, 2025 | SEC |
| Nov 18, 20254:00 PM ET | Perceptive Advisors LLCand 2 others | 13G | 9.99%6.77M shares | New | Nov 11, 2025 | SEC |
| Nov 14, 20258:12 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 4.37%2.24M shares | −4.57 ppfrom 8.94%Below 5% | Sep 30, 2025 | SEC |
| Feb 14, 20256:15 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 9.90%5.05M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20255:16 PM ET | Kynam Capital Management, LPand 2 others | 13G | 9.80%4.99M shares | New | Dec 31, 2024 | SEC |
| Feb 14, 20252:25 PM ET | Foresite Capital Fund VI LPand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2024 | SEC |
| Feb 14, 20258:46 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 8.94%4.56M shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20259:35 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 3.00%1.53M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 29, 20255:12 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 1.80%945.4K shares | −4.10 ppfrom 5.90%Below 5% | Jan 27, 2025 | SEC |
| Jan 29, 20255:09 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 5.90%3.05M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Omega Fund VII, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Blue Owl Capital Holdings LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Adage Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Nov 1, 2024 | Forbion Growth Sponsor FEAC I B.V. | 13D/AOld format | – | – | – | SEC |
| Oct 21, 202412:35 PM ET | Fonds de solidarite des travailleurs et des travailleuses du Quebec | 13G/A | 4.50%2.03M shares | –Below 5% | Sep 30, 2024 | SEC |
| Oct 18, 2024 | Forbion Growth Sponsor FEAC I B.V. | 13D/AOld format | – | – | – | SEC |
| Feb 26, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
| Feb 23, 2024 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Feb 23, 2024 | Foresite Capital Fund VI LP | 13GOld format | – | New | – | SEC |
| Feb 22, 2024 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 21, 2024 | Lumira Capital Investment Management Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Omega Fund VII, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Forbion Capital Fund III Cooperatief U.A. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Blue Owl Capital Holdings LP | 13GOld format | – | New | – | SEC |
| Nov 13, 2023 | Forbion Capital Fund III Cooperatief U.A. | 13GOld format | – | New | – | SEC |
| Nov 13, 2023 | Forbion Growth Sponsor FEAC I B.V. | 13DOld format | – | New | – | SEC |
| Nov 13, 2023 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Nov 8, 2023 | Lumira Capital Investment Management Inc. | 13DOld format | – | New | – | SEC |
| Nov 7, 2023 | Fonds de Solidarite des Travailleurs du Quebec | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell enGene Therapeutics Inc. shares.
No Form 144 notices for enGene Therapeutics Inc. are on file.